Cash, cash equivalents, other financial assets and marketable securities were $315.3M as of March 31, 2025, compared to cash, cash equivalents, other financial assets and marketable securities of $182.6M as of December 31, 2024. Gross proceeds from public offering in Q1 2025 were $150M. Other financial assets are comprised of money market funds, and marketable securities are comprised of investment grade bonds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GHRS:
- Psychedelic: Exclusive talk with retreat provider ONE Retreats
- Psychedelic: Exclusive talk with biotech company Clearmind Medicine
- Psychedelic: atai Life Sciences, NRx report quarterly results
- Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
- Guggenheim starts GH Research at Buy, sees long-term upside potential